Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta - Wikidata - wikimedia - TriplyDB

Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta

Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta

http://www.wikidata.org/entity/Q28591284

about

The AP-2 family of transcription factors Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo AP2 transcription factor induces apoptosis in retinoblastoma cells Transcription factor gene AP-2 gamma essential for early murine development Transcriptional activation by AP-2alpha is modulated by the oncogene DEK Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells Activation of somatostatin receptor II expression by transcription factors MIBP1 and SEF-2 in the murine brain Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation Determination of genetic predisposition to patent ductus arteriosus in preterm infants Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells Brainstem levels of transcription factor AP-2 in rat are changed after treatment with phenelzine, but not with citalopram Loss of AP-2delta reduces retinal ganglion cell numbers and axonal projections to the superior colliculus.The AP-2 Transcription Factor APTF-2 Is Required for Neuroblast and Epidermal Morphogenesis in Caenorhabditis elegans Embryogenesis A heart-hand syndrome gene: Tfap2b plays a critical role in the development and remodeling of mouse ductus arteriosus and limb patterning Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties Terminal renal failure in mice lacking transcription factor AP-2 beta Transcription factor AP-2β regulates the neurotransmitter phenotype and maturation of chromaffin cells The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney Strain-dependent perinatal lethality of Ovol1-deficient mice and identification of Ovol2 as a downstream target of Ovol1 in skin epidermis Conditional deletion of activating protein 2alpha (AP-2alpha) in the developing retina demonstrates non-cell-autonomous roles for AP-2alpha in optic cup development Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice Transcription factor AP-2gamma regulates murine adenosine deaminase gene expression during placental development AP-2δ is a crucial transcriptional regulator of the posterior midbrain.Novel activator protein-2alpha splice-variants function as transactivators of the ovine placental lactogen gene.Risk factors for the neurohumoral alterations underlying personality disturbances.Structural organization and promoter analysis of murine heat shock transcription factor-1 gene.Pathway signature and cellular differentiation in clear cell renal cell carcinoma.New Myc-interacting proteins: a second Myc network emerges.Mechanisms of apoptosis by c-Myc.Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease Genome-wide prediction of imprinted murine genes Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder.Induction of AP-2alpha expression by adenoviral infection involves inactivation of the AP-2rep transcriptional corepressor CtBP1.Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.Genetic mechanisms of behavior--don't forget about the transcription factors.

P2860

b17b828c6e8881b7fd7af8745f3346b099907ded

P248

Q21184171-7A080343-A9DF-4ACB-B9C4-674598575EC3 Q21260382-E8BA39D6-7F3E-4696-8EE2-53AFE3AFA57B Q24291566-D89A4C2A-93F0-409D-85F6-7AA63DF6D5C8 Q24299957-3CADB48B-74F3-4AD3-85EC-4EE4E9A0A2E4 Q24337909-3A093DA6-57D8-4C23-BD6C-0191E2F5ED60 Q24537286-F0B2C852-E67E-47C5-80D3-F8CC62C5882B Q24550724-29A1DFD4-2AD8-4C1E-B962-13AF8FE2B2C2 Q24550911-BE0B1447-3A75-495F-9574-8E27D48F03BD Q24554497-B45584E2-9778-4D97-9A09-EEFFE6A5966A Q24554732-5C9FA7CD-4F5C-4F63-93BE-58A84A3E0B52 Q24601085-7ED23EB9-57B4-4E35-8D12-ECC2AEBDDC3D Q24616799-0084805A-FCA1-4EC9-8F6E-316EF7889B8D Q24645265-A7521319-5D1B-4735-8735-BD56A2D68E77 Q24648448-4F40393A-8904-4FC6-B094-0CA245191CD9 Q24798986-68882C15-7B86-4E7C-8841-53F51C69F459 Q27300762-88135758-F318-409A-81AE-E739D9341B3F Q27308855-3206E766-B1F6-4AE0-9209-81DE9938BD3F Q28508787-084755C1-34D7-4203-9DB8-A694C74141CE Q28510687-3FAD3755-AC36-4976-8E4F-D49F69F20234 Q28513883-2E28B42E-0A45-4B52-9A4F-A74E06EF6FC8 Q28565794-88580C09-0267-43F7-96A7-B30D11A454AF Q28581878-0F48953F-CC35-458F-9589-4801B2CADAD7 Q28584785-24DFCC38-4F5B-4871-B122-08989AD2DD89 Q28588275-65F01189-78C3-4371-96C2-7CFD75274E94 Q28591920-07D4E85A-C953-460C-AE56-92E857BCB91D Q28593373-6BDEF22B-D80E-411A-8B24-FA9022E71878 Q28594621-4CABA1A9-94C3-4EED-ACFF-C02548A3C780 Q30664043-AF08157E-0AC3-4CDD-9B2F-A0D6B7A8BA40 Q30932949-5435CA84-A948-4647-81AA-D17609D74100 Q31965950-4D2D4ECD-AEA0-4304-B7D4-2DBF5B3CAFA6 Q33587345-DCDC7389-8879-4A36-A2B0-415C5BA56F9B Q33667300-30253752-EEAE-4127-AF12-B0B306432EDD Q33667315-39CF63AF-C19F-4A23-AD76-8FA8C06FE8A3 Q33784342-ED51F4BB-0817-4C21-BCE4-1CAFA629B457 Q33841575-8E8D8E0B-DD88-4123-AA50-9189F4C9E039 Q33864543-D5E5E1E3-FE8A-49B8-844B-CA02F0B9B4EE Q33948225-7D46E9BF-5CB0-4707-BDA4-A07CD382AB0D Q34134402-F7255675-3BCA-4311-B933-7FBC344BAABB Q34149151-DC2180D5-C667-4076-9A7E-BB563F889FFE Q34349004-0F63F5CE-9DED-41D0-A09B-045423E3B41F

P2860

Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta

http://www.wikidata.org/entity/Q28591284

description

1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 1997

@ast

im August 1997 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 1997/08/01)

@sk

vědecký článek publikovaný v roce 1997

@cs

wetenschappelijk artikel (gepubliceerd op 1997/08/01)

@nl

наукова стаття, опублікована в серпні 1997

@uk

مقالة علمية (نشرت في أغسطس 1997)

@ar

name

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@ast

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@en

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@nl

type

label

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@ast

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@en

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@nl

prefLabel

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@ast

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@en

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@nl

P1433

Q28591284-D1B12933-D7EE-455E-8358-0907B6E0371E

P1476

Q28591284-579D02ED-1D25-429D-A3AB-0CB90DA8E6D5

P2093

Q28591284-00E58FF8-508C-45D9-A472-D890DEC9FEAA

Q28591284-00FD62FD-A695-449F-9552-EA0108AA5B35

Q28591284-0EB2CEAD-3704-441D-88EE-7F7EC238F37A

Q28591284-1E19DBEB-B20C-46E9-9B57-EE81A97BE5E4

Q28591284-1F445D67-138A-44E1-BB53-6F416870181E

Q28591284-2209D31E-69D7-4464-9AC8-24DB98F91411

Q28591284-277337D6-9A70-44C9-A5D4-C8FFF88D9990

Q28591284-92640B93-1639-4066-8B8A-2C2160D0B45B

Q28591284-BD701DD1-F762-4CA0-8E8F-A4BE2427B902

Q28591284-EA2A28E1-507E-4FE8-98FF-F423663CB81B

P2860

Q28591284-03809677-4177-4BB7-B5CE-0AF215004B42

Q28591284-06CF0506-E39F-4DC7-A969-FDF8ED2DDF9C

Q28591284-3D62E2A7-3E7B-4755-8E67-FAFB89625948

Q28591284-3DDFB18F-7D3E-4224-9FBC-06FB5156924D

Q28591284-400AF924-AA52-4AED-B8C0-F349A2676CFE

Q28591284-4B30C5D0-5815-45DF-9A01-1CB9379AE416

Q28591284-4D7F6C86-C6A9-4AD4-A222-34125E261F83

Q28591284-56E68101-6EA8-4555-A29B-B586C84FC4F6

Q28591284-5FA3E84F-E134-4E02-AF0F-72EE326C83BC

Q28591284-64EE83E7-10F2-4DC4-96E9-796B7A93107D

P304

Q28591284-B7B7F857-7059-4F41-A04E-FFE2D5B36439

P31

Q28591284-E984CC23-C1B8-43F9-ADC5-A7177D0E6632

P3181

Q28591284-DFE35EF9-2127-41B2-BB8E-6CD858B9CB43

P356

Q28591284-6223F238-330F-4895-A37F-C7AFF7688C9D

P433

Q28591284-BCC90283-4834-4F8B-921C-5E9108EBDDD8

P478

Q28591284-284EE2AA-BCA6-4E0E-9812-46DA507EE40F

P577

Q28591284-21A66FAB-8F4B-49C5-93A5-029BBFE0802A

P5875

Q28591284-336AD018-68E1-44AB-A63F-1687C713FA51

P698

Q28591284-40C5BFAB-6363-4CFF-A85D-8E73846DD2E9

P921

Q28591284-198AB34F-8935-4800-B073-8702B83D2ACE

Q28591284-3703DC49-10CE-441E-8981-9A1E268E66A9

P932

Q28591284-0B05498C-357A-4F37-A555-B8645A98F38C

P3181

P356

P1433

Genes & Development

P1476

Enhanced apoptotic cell death ...... transcription factor AP-2beta

@en

P2093

A. Pscherer

http://www.w3.org/2001/XMLSchema#string

C. Dixkens

http://www.w3.org/2001/XMLSchema#string

C. Roth

http://www.w3.org/2001/XMLSchema#string

G. Mücher

http://www.w3.org/2001/XMLSchema#string

J. Becker

http://www.w3.org/2001/XMLSchema#string

J. Weis

http://www.w3.org/2001/XMLSchema#string

K. Zerres

http://www.w3.org/2001/XMLSchema#string

L. Guay-Woodford

http://www.w3.org/2001/XMLSchema#string

M. Moser

http://www.w3.org/2001/XMLSchema#string

R. Buettner

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of a second AP-2 transcription factor: AP-2 beta

Transcriptional activation by Myc is under negative control by the transcription factor AP-2

The genomic structure of the human AP-2 transcription factor

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors

Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins

Analysis of the DNA-binding and activation properties of the human transcription factor AP-2

High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones

Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice

Transcription factor AP-2 essential for cranial closure and craniofacial development

P304

1938–1948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1034675

http://www.w3.org/2001/XMLSchema#string

P356

10.1101/GAD.11.15.1938

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

1997-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13949497

http://www.w3.org/2001/XMLSchema#string

P698

9271117

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

Transcription factor AP-2 beta

P932

316415

http://www.w3.org/2001/XMLSchema#string